Basic FGF, EGF, and PDGF modify TGFβ-induction of smooth muscle cell phenotype in human prostatic stromal cells

Prostate

Volumn 35, Issue 2, 1998, Pages 125-134

  Peehl, Donna M ^a   Sellers, Robert G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermal growth factor; Fibroblast growth factor; Platelet derived growth factor; Prostate; Smooth muscle; Transforming growth factor

Indexed keywords

ALPHA ACTIN; ANDROGEN; BASIC FIBROBLAST GROWTH FACTOR; CALCITRIOL; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; RETINOIC ACID; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REGULATORY MECHANISM; SMOOTH MUSCLE;

ACTINS; ADENOCARCINOMA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PROSTATIC NEOPLASMS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0031897292     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980501)35:2<125::AID-PROS6>3.0.CO;2-I     Document Type: Article

References (57)

1. Cunha GR: Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer [Suppl] 1994;74:1030-1044.
2. McNeal JE: Prostate. In Sternberg SS (ed): "Histology for Pathologists," New York: Raven Press, 1992:749-763.
3. Shapiro E, Hartanto V, Lepor H: Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle. Prostate 1992;20:259-267.
4. Hayward SW, Cunha GR, Dahiya R: Normal development and carcinogenesis of the prostate. Ann NY Acad Sci 1996;784:50-62.
5. Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK: Influence of transforming growth factor β1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 1993;22:183-197.
6. Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM, Lee C: Stromal cells of the human prostate: Initial isolation and characterization. Prostate 1996;28:89-97.
7. Peehl DM, Seller RG: Induction of smooth muscle cell phenotypes in cultured human prostatic stromal cells. Exp Cell Res 1997;232:208-215.
8. Sappino AP, Schurch W, Gabbiani G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63:144-161.
9. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-111.
10. McNeal JE, Kindrachuk RA, Freiha FS, Bostwick DG, Redwine EA, Stamey TA: Patterns of progression in prostate cancer. Lancet 1986;1:60-63.
11. Kabalin JN, Peehl DM, Stamey TA: Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate 1989;14:251-263.
12. Peehl DM: Culture of human prostatic epithelial cells. In Freshney RI (ed): "Culture of Epithelial Cells," New York: Wiley-Liss, Inc., 1992:159-180.
13. Tsao MC, Walthall BJ, Ham RG: Clonal growth of normal human epidermal keratinocytes in a defined medium. Cell Physiol 1982;110:219-229.
14. McKeehan WL, Adams PS: Heparin-binding growth factor/ prostatropin attenuates inhibition of rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro 1988;24:243-246.
15. Morton DM, Barrack ER: Modulation of transforming growth factor β1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res 1995;55:2596-2602.
16. Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG: Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab 1994;79:1410-1415.
17. Story MT, Sasse J, Jacobs SC, Lawson RK: Prostatic growth factor: Purification and structural relationship to basic fibroblast growth factor. Biochemistry 1987;26:3843-3849.
18. Mydlo JH, Michaeli J, Heston WDW, Fair WR: Expression of basic fibroblast growth factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. Prostate 1988;13:241-247.
19. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia. Prostate 1990;16:71-80.
20. Begun FP, Story MT, Hopp KA, Shapiro E, Lawson RK: Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic human prostates. J Urol 1995;153:839-843.
21. Story MT, Livingston B, Baeten L, Swartz SJ, Jacobs SC, Begun FP, Lawson RK: Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 1989;15:355-365.
22. Sherwood ER, Fong C-J, Lee C, Kozlowski JM: Basic fibroblast growth factor: A potential mediator of stromal growth in the human prostate. Endocrinology 1992;130:2955-2963.
23. Mason IF: The ins and outs of fibroblast growth factors. Cell 1994;78:547-552.
24. Story MT, Hopp KA, Molter M, Meier DA: Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors 1994; 10:269-280.
25. Levine AC, Ren M, Huber GK, Kirschenbaum A: The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 1992;130:2413-2419.
26. Peehl DM, Sellers RG, Wong ST: Defined medium nor normal adult human prostatic stromal cells. In Vitro Cell Dev Biol 1998; in press.
27. Fowler JE Jr, Lau JLT, Ghosh L, Mills SE, Mounzer A: Epidermal growth factor and prostatic carcinoma: An immunohistochemical study. J Urol 1988;139:857-861.
28. Ching KZ, Ramsey E, Pettigrew N, D'Cunha R, Jason M, Dodd JG: Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem 1993;126:151-158.
29. Yang Y, Chisholm GD, Habib FK: Epidermal growth factor and transforming growth factor α concentrations in BPH and cancer of the prostate: Their relationships with tissue androgen levels. Br J Cancer 1993;67:152-155.
30. Sherwood ER, Lee C: Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate. World J Urol 1995;13:290-296.
31. Harper ME, Goddard L, Glynne-Jones E, Wilson DW, Price-Thomas M, Peeling WB, Griffiths K: An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors. Prostate 1993;23:9-23.
32. Cohen DW, Simak R, Fair WR, Melamed J, Scher HI, Cordon-Cardo C: Expression of transforming growth factor-α and the epidermal growth factor receptor in human prostate tissues. J Urol 1994;152:2120-2124.
33. Giri DK, Pal R, Wadhwa SN, Talwar GP: Immunohistochemical localization of transforming growth factor-α, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates. Carcinogenesis 1995;16:729-733.
34. Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J, Cordon-Cardo C: Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms. Clin Cancer Res 1995;1:545-550.
35. Derynck R: Transforming growth factor α. Cell 1988;54:593-595.
36. Carpenter G, Cohen S: Epidermal growth factor. J Biol Chem 1990;265:7709-7712.
37. Gleason PE, Jones JA, Regan JS, Salvas DB, Eble JN, Lamph WW, Vlahos CJ, Huang W-L, Falcone JF, Hirsch KS: Platelet derived growth factor (PDGF), androgens and inflammation: Possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993;149:1586-1592.
38. Vlahos CJ, Kriauciunas TD, Gleason PE, Jones JA, Eble JN, Salvas D, Falcone JF, Hirsch KS: Platelet-derived growth factor induces proliferation of hyperplastic human prostatic stromal cells. J Cell Biochem 1993;52:404-413.
39. Westermark B, Heldin C-H: Platelet-derived growth factor in autocrine transformation. Cancer Res 1991;51:5087-5092.
40. 3 on primary cultures of human prostatic cells. Cancer Res 1994;54:1-6.
41. Glick AB, Flanders KC, Danielpour D, Yuspa SH, Sporn MB: Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regul 1989;1:87-97.
42. Sporn MB, Roberts AB: Interactions of retinoids and transforming growth factor-β in regulation of cell differentiation and proliferation. Mol Endocrinol 1991;5:3-7.
43. 3 enhances antiproliferative effect and transcription of TGF-β-1 on human keratinocytes in culture. J Cell Physiol 1992; 151:579-587.
44. 3 in NRP-152 rat prostatic epithelial cells. J Cell Physiol 1996;166:231-239.
45. Hayward SW, Rosen MA, Cunha GR: Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol [Suppl] 1997;79:18-26.
46. Sadi MV, Barrack ER: Androgen receptors and growth fraction in metastatic prostate cancer as predictors of time to tumour progression after hormonal therapy. Cancer Surv 1991;11:195-215.
47. Mohler JL, Chen Y, Hamil K, Hall SH, Cidlowski JA, Wilson EM, French FS, Sar M: Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Clin Cancer Res 1996;2:889-895.
48. Collins AT, Zhiming B, Gilmore K, Neal DE: Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: Oestrogen regulation of the androgen receptor. J Endocrinol 1994;143:269-277.
49. Birukov KG, Frid MG, Rogers JD, Shirinsky VP, Koteliansky VE, Campbell JH, Campbell GR: Synthesis and expression of smooth muscle phenotype markers in primary culture of rabbit aortic smooth muscle cells: Influence of seeding density and media and relation to cell contractility. Exp Cell Res 1993;204: 46-53.
50. Ronnov-Jessen L, Peterson OW: Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts. Lab Invest 1993;68:696-707.
51. Kato S, Shanley JR, Fox JC: Serum stimulation, cell-cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro. Am J Pathol 1996;149:687-697.
52. Sherwood ER, Berg LA, McEwan RN, Pasciak RM, Kozlowski JM, Lee C: Two-dimensional protein profiles of cultured stromal and epithelial cells from hyperplastic human prostate. J Cell Biochem 1989;40:201-214.
53. Yazawa H, Saita Y, Iida E, Honma Y, Morita T, Honda K: Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J Urol 1994;152:2173-2177.
54. Cussenot O, Berthon P, Cochand-Priollet B, Maitland NJ, LeDuc A: Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. Exp Cell Res 1994;214:83-92.
55. Zhang J, Hess MW, Thurner M, Hobisch A, Radmayr C, Cronauer MV, Hittmair A, Culig Z, Bartsch G, Klocker H: Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997; 30:117-129.
56. Kooistra A, Elissen NMJ, König JJ, Vermey M, van der Kwast TH, Romijn JC, Schröder FH: Immunocytochemical characterization of explant cultures of human prostatic stromal cells. Prostate 1995;27:42-49.
57. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC: Association of transforming growth factor-β1 with prostate cancer: An immunohistochemical study. Hum Pathol 1993;24:4-9.